⚠️ This provider averages 1.1K services per working day — physically unusual for an individual practitioner
Based on 2.9M total services over 10 years (250 working days/year). Learn about impossible service volumes →
This provider's $25.9M in total Medicare payments ranks in the 99th percentile of Rheumatology providers nationally.
Averaging 1.1K services per working day raises questions about billing patterns.
Medicare payments to this provider grew 198% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $15.37 | $8.62 | 1.78x | $6.75 | $1.2M | 138.6K | 23 |
| 2015 | $14.79 | $8.73 | 1.69x | $6.06 | $1.3M | 147.2K | 24 |
| 2016 | $13.29 | $8.53 | 1.56x | $4.76 | $1.8M | 208.7K | 20 |
| 2017 | $14.92 | $9.29 | 1.61x | $5.63 | $2.1M | 227.5K | 23 |
| 2018 | $17.09 | $10.45 | 1.64x | $6.64 | $2.2M | 213.3K | 23 |
| 2019 | $16.59 | $9.51 | 1.74x | $7.08 | $3.1M | 329.1K | 24 |
| 2020 | $16.80 | $9.67 | 1.74x | $7.13 | $3.5M | 366.2K | 25 |
| 2021 | $18.03 | $9.26 | 1.95x | $8.77 | $3.6M | 389.0K | 25 |
| 2022 | $19.69 | $8.69 | 2.27x | $11.00 | $3.4M | 395.6K | 25 |
| 2023 | $20.38 | $8.08 | 2.52x | $12.30 | $3.6M | 441.5K | 28 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 1.9M | $10.0M | $5.38 | 1.95x |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 156.8K | $5.7M | $36.50 | 1.71x |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 161.1K | $2.0M | $12.37 | 2.43x |
| J3262 | Injection, tocilizumab, 1 mg | 435.0K | $1.9M | $4.30 | 1.70x |
| J0897 | Injection, denosumab, 1 mg | 80.5K | $1.2M | $14.99 | 1.53x |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 18.1K | $1.1M | $58.21 | 1.75x |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 5.0K | $620.3K | $123.83 | 1.59x |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 7.0K | $476.0K | $67.94 | 2.17x |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | 11.8K | $418.2K | $35.35 | 1.84x |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 40.7K | $321.5K | $7.89 | 1.58x |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | 3.6K | $291.6K | $81.41 | 2.50x |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 3.3K | $286.8K | $86.34 | 1.55x |
| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 7.3K | $250.3K | $34.39 | 2.91x |
| 20610 | Aspiration and/or injection of fluid from large joint | 3.6K | $192.3K | $53.17 | 1.94x |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 6.2K | $189.8K | $30.56 | 3.27x |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 23.4K | $116.9K | $4.99 | 1.77x |
| J7324 | Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 724 | $103.1K | $142.43 | 2.59x |
| J7329 | Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg | 8.8K | $91.7K | $10.42 | 2.40x |
| 20552 | Injections of trigger points in 1 or 2 muscles | 1.9K | $84.1K | $43.28 | 1.54x |
| 96372 | Injection of drug or substance under skin or into muscle | 5.6K | $74.8K | $13.43 | 3.19x |
This provider submits charges 1.91 times higher than what Medicare actually pays.
A markup ratio of 1.91x means for every $100 Medicare pays, this provider initially charges $191. This is lower than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Rheumatology providers in NJ for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Stephen Soloway, M.D.,FACP.,FACR.,CCD | Vineland, NJ | $42.7M | ✓ Clear |
| Steven Golombek, M.D. | Dover, NJ | $34.7M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data